ADAPTIMMUNE THERAPEUTICS-ADR (ADAP)

US00653A1079 - ADR

1.19  -0.02 (-1.65%)

After market: 1.18 -0.01 (-0.84%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
60.28M27.15M6.15M3.96M1.12M
Operating Expenses
190.97M188.81M168.40M137.36M140.89M
Research and Development
126.51M127.73M111.09M91.57M97.50M
Selling, General, and Administrative Expenses
64.46M61.09M57.31M45.80M43.39M
Operating Income
-130.69M-161.67M-162.25M-133.41M-139.77M
Interest Income/Expense
5.96M1.54M1.10M2.40M2.79M
Other Income/Expense
-807.00K-540.00K3.85M1.07M60.00K
Non Recurring Items
13.00M-2.30MN/AN/AN/A
Income Before Taxes
-112.53M-162.96M-157.30M-129.93M-136.92M
Income Tax
1.34M2.50M790.00K160.00K240.00K
Net Income
-113.87M-165.46M-158.09M-130.09M-137.17M
EBITDA
-120.85M-155.59M-155.68M-125.81M-131.76M
 
Per Share Data
EPS Diluted Total Ops
-0.50-0.91-0.91-0.80-1.17
Non GAAP EPS
-0.66-1.00-1.02-0.96-1.31
 
Statistics
Profit Margin
-188.90%-609.43%-2570.57%-3285.10%-12247.32%
Operating Profit Margin
-216.80%-595.47%-2638.21%-3368.94%-12479.46%

All data in USD

Charts